PETROS PHARMACEUTICALS |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.6399 USD | +0.87% |
|
-8.31% | -54.62% |
| Apr. 23 | Petros, Lemonaid Health Collaborate to Expand Stendra Availability | MT |
| Apr. 16 | Petros Gets 'Positive' FDA Response Over Technology Component in Stendra OTC Process | MT |
Chart calendar Petros Pharmaceuticals
d9c2f9a207ba7f904a69cb207e06aa58._8NBXKQEM8Z0j2npVNPqywY9b-3mvoqtew1j364nHmk.to52NNFAAY9EtiSAI7eP-D9-GYeI0M_0NXQVjsNlXSaMuyNv5zNs8z7_IA~28e58541198e99aafac75cbc4e64f54b
Upcoming events on Petros Pharmaceuticals
No events available
Past events on Petros Pharmaceuticals
| 2022-08-15 08:00 am | Interim 2022 Earnings Release |
| 2022-05-16 05:00 pm | Q1 2022 Earnings Release |
| 2022-05-04 01:00 pm | Planet MicroCap Showcase |
| 2022-04-01 07:00 am | FY 2021 Earnings Release |
| 2022-03-09 02:00 pm | Investor Summit Group Virtual Investor Summit |
| 2022-03-07 | Investor Summit Group Virtual Investor Summit |
| 2022-01-16 | Biotech Showcase |
| 2022-01-10 07:00 am | H.C. Wainwright BioConnect Conference |
| 2022-01-09 | Biotech Showcase |
| 2021-12-08 01:35 pm | Benzinga Global SmallCAP Conference |
| 2021-11-17 01:15 pm | FY Investor Summit |
| 2021-11-15 04:30 pm | Q3 2021 Earnings Release |
| 2021-09-30 02:40 pm | Benzinga Healthcare Small Cap Conference |
| 2021-09-13 07:00 am | H.C. Wainwright Global Investment Conference |
| 2021-08-18 04:00 pm | SNN Network Summer Investor Conference |
| 2021-08-17 12:30 pm | Q3 Investor Summit |
| 2021-08-17 09:25 am | Interim 2021 Earnings Release |
| 2021-07-14 03:30 pm | Issuer Direct Access to Giving Virtual Investor Conference |
| 2021-06-10 04:00 pm | LD Micro Invitational Investor Conference |
| 2021-05-18 09:30 am | Investor Summit |
Annual results
| Fiscal Period | December | 2022 | 2023 | 2024 |
|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 5,82 7,70 -24.41% | 5,67 |
|
EBITDA | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -13,6 -10,8 -25.92% | -12,2 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -8,16 -10,9 24.9% | -12,8 |
|
Net income Million USD | Released Forecast Spread | -20,0 | -8,16 -10,9 24.9% | -12,8 |
|
EPS USD | Released Forecast Spread | -9,68 | -6,35 -5,15 -23.3% | -6,01 |
| Announcement Date | 31/03/23 | 01/04/24 | - |
Quarterly results
| Fiscal Period | December | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 1,55 | 1,45 | 1,43 | 1,40 | 1,38 |
|
EBIT Million USD | Released Forecast Spread | -2,20 | -2,90 | -2,99 | -3,09 | -3,19 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -2,35 | -3,05 | -3,15 | -3,24 | -3,34 |
|
Net income Million USD | Released Forecast Spread | -2,35 | -3,05 | -3,15 | -3,24 | -3,34 |
|
EPS USD | Released Forecast Spread | -1,11 | -1,44 | -1,48 | -1,52 | -1,57 |
| Announcement Date | - | - | - | - | - |
Past sector events for Petros Pharmaceuticals
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- PTPI Stock
- Calendar Petros Pharmaceuticals
